Renaissance Capital LLC Grows Stock Position in Kenvue Inc. $KVUE

Renaissance Capital LLC grew its holdings in shares of Kenvue Inc. (NYSE:KVUE) by 55.8% in the 3rd quarter, Holdings Channel reports. The fund owned 980,436 shares of the company’s stock after buying an additional 351,259 shares during the period. Kenvue accounts for 8.9% of Renaissance Capital LLC’s investment portfolio, making the stock its 2nd largest holding. Renaissance Capital LLC’s holdings in Kenvue were worth $15,912,000 at the end of the most recent quarter.

A number of other hedge funds also recently made changes to their positions in the stock. Trust Co. of Vermont grew its holdings in shares of Kenvue by 266.8% during the 2nd quarter. Trust Co. of Vermont now owns 1,581 shares of the company’s stock valued at $33,000 after purchasing an additional 1,150 shares during the last quarter. Future Financial Wealth Managment LLC acquired a new stake in Kenvue in the third quarter valued at approximately $49,000. First Pacific Financial bought a new stake in shares of Kenvue during the second quarter worth $54,000. Ransom Advisory Ltd acquired a new position in shares of Kenvue during the first quarter worth $56,000. Finally, UMB Bank n.a. lifted its stake in shares of Kenvue by 22.3% in the 2nd quarter. UMB Bank n.a. now owns 2,853 shares of the company’s stock valued at $60,000 after acquiring an additional 521 shares during the last quarter. 97.64% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In other Kenvue news, Director Jeffrey C. Smith purchased 3,200,000 shares of the firm’s stock in a transaction on Friday, December 12th. The stock was purchased at an average cost of $17.37 per share, for a total transaction of $55,584,000.00. Following the acquisition, the director owned 27,307,632 shares in the company, valued at approximately $474,333,567.84. The trade was a 13.27% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 0.17% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts recently weighed in on KVUE shares. Zacks Research upgraded Kenvue from a “strong sell” rating to a “hold” rating in a research report on Wednesday, November 26th. Canaccord Genuity Group restated a “hold” rating and set a $15.00 price target (down from $26.00) on shares of Kenvue in a report on Wednesday, October 29th. Citigroup lowered their price objective on Kenvue from $20.00 to $17.00 and set a “neutral” rating for the company in a research note on Thursday, October 9th. Johnson Rice reiterated a “neutral” rating on shares of Kenvue in a research report on Tuesday, October 28th. Finally, JPMorgan Chase & Co. reduced their target price on shares of Kenvue from $24.00 to $21.00 and set an “overweight” rating on the stock in a report on Friday, October 10th. One analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating and twelve have issued a Hold rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of $20.23.

Kenvue Price Performance

Kenvue stock opened at $17.33 on Wednesday. The stock’s 50 day moving average is $16.53 and its 200 day moving average is $18.63. Kenvue Inc. has a one year low of $14.02 and a one year high of $25.17. The firm has a market cap of $33.20 billion, a P/E ratio of 23.11 and a beta of 0.60. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.98 and a quick ratio of 0.69.

Kenvue (NYSE:KVUE) last released its quarterly earnings results on Monday, November 3rd. The company reported $0.28 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.27 by $0.01. Kenvue had a net margin of 9.55% and a return on equity of 20.02%. The firm had revenue of $3.76 billion during the quarter, compared to analyst estimates of $3.83 billion. During the same quarter last year, the business earned $0.28 EPS. The company’s revenue was down 3.5% compared to the same quarter last year. Kenvue has set its FY 2025 guidance at 1.000-1.050 EPS. As a group, research analysts expect that Kenvue Inc. will post 1.14 EPS for the current year.

Kenvue Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Wednesday, November 26th. Shareholders of record on Wednesday, November 12th were given a dividend of $0.2075 per share. The ex-dividend date of this dividend was Wednesday, November 12th. This represents a $0.83 dividend on an annualized basis and a yield of 4.8%. Kenvue’s dividend payout ratio is 110.67%.

About Kenvue

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.